Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Irene Romera
A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Following the Results of the EMPA-REG OUTCOME Trial With Empagliflozin, Is It Possible to Speak of a Class Effect?
International Journal of General Medicine
Medicine
Related publications
Glucagon-Like Peptide 1 Receptor Agonists: A New Approach to Type 2 Diabetes Management
South African Family Practice
A Retrospective Study of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Diabetes After Transplantation
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Correction To: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Clinical Drug Investigation
Medicine
Pharmacology
The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis
PLoS ONE
Multidisciplinary
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: A Systematic Review and Mixed-Treatment Comparison Analysis
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Comprehensive Review of How to Weigh the Options, Select the Right Patients, and Maximize Benefits
Endocrine Practice
Medicine
Endocrinology
Metabolism
Diabetes
Gastrointestinal Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
Review of Glucagon‐Like Peptide‐1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus in Patients With Chronic Kidney Disease and Their Renal Effects
Journal of Diabetes
Endocrinology
Metabolism
Diabetes
Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
